Anatara Lifesciences Ltd ANR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.04
- Day Range
- A$0.05–0.05
- 52-Week Range
- A$0.02–0.05
- Bid/Ask
- A$0.04 / A$0.05
- Market Cap
- A$7.72 Mil
- Volume/Avg
- 111,942 / 266,695
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
Valuation
|
Metric
|
ANR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.09 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
ANR
Financial Strength
|
Metric
|
ANR
|
|---|---|
Quick Ratio | 8.57 |
Current Ratio | 8.90 |
Interest Coverage | — |
Quick Ratio
ANR
Profitability
|
Metric
|
ANR
|
|---|---|
Return on Assets (Normalized) | −108.35% |
Return on Equity (Normalized) | −133.29% |
Return on Invested Capital (Normalized) | −132.82% |
Return on Assets
ANR
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Tmzjscbwk | Bdns | $562.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Ffbybtp | Whppvv | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Gqjzynp | Lynlh | $99.5 Bil | |
MRNA
| Moderna Inc | Rxlnmdtc | Fwylk | $38.8 Bil | |
ARGX
| argenx SE ADR | Fbzvdshy | Lyqg | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Lbtnwjsd | Gjwt | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Gwrwgkfw | Fhjpyn | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Chktqzg | Zhhbq | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Csyzhysqyv | Mlmtgx | $12.5 Bil | |
INCY
| Incyte Corp | Yqlgcwlx | Dkphc | $11.6 Bil |